·        Bruhat A., Dréau D., Drake M.E., Tourmente S., Chapel S., Couderc J.L., Dastugue B., 1993.   Intronic and 5' flanking sequences of the drosophila ß3 tubulin gene are essential to conferecdysone responsiveness. Mol. Cell.  Endocr. 94:61-71.

·        Dréau D., Lallès J.P., Philouze-Romé V., Toullec R., Salmon H., 1994. Local and systemic immune responses to        soybean protein ingestion in early weaned pigs. J. Anim. Sci., 72: 2090-2098.

·        Dréau D., Morton D., Foster M., Swiggett J.P., Sonnenfeld G., 1997. Immune alterations in male and female mice                  after 2-deoxy-D-glucose administration. Physiol Behav, 62 (6): 1325-1331.  Related  Article

·        Dréau D., Morton D., Fowler N., Foster M., Sonnenfeld G., 1998. Effects of 2-deoxy-D-glucose administration on

      immune parameters in mice. Immunopharmacology, 39 (3): 201-213. Related Article

·        Dréau D., Bosserhoff A.-K., White R.L., Holder W.D, 1999. Melanoma-inhibitory activity protein concentrations in the blood   of melanoma patients treated with immunotherapy. Oncology Research, 11: 55-61. Related Article

·        Dréau D., Lallès J.P., 1999. Contribution to the study of gut hypersensitivity reactions to soybean proteins in           preruminant calves and early-weaned piglets. Livest. Prod. Sci., 60: 209-218.

·        Dréau D., Sonnenfeld G., Morton D.S., Fowler N., Lyte M., 1999. Effects of social conflict on immune responses                 and Escherichia coli growth within peritoneal implant chambers in mice. Physiol Behav, 67: 133-140. Related Article

·        Dréau D., Culberson C., Wyatt S., Holder W.D, 2000. Human Papilloma virus in melanoma biopsy specimens and 

      its   relation to melanoma progression. Ann. Surg., 231: 664-671. Related Article

·        Dréau D., Foster M., Morton D.S., Fowler N., Kinney K., Sonnenfeld G, 2000. Immune alterations in three mouse

     strains following 2-deoxy-D-glucose administration. Physiol Behav, 70:1-8.  Related Article

·        Bosserhoff A.K., Dréau D., Hein R., Landthaler M., Holder W.D., Buettner R., 2001. Melanoma inhibitory activity (MIA),

     a serological marker of malignant melanoma. Recent Results in Cancer Res., 158:158-168. Related Article

·        Dréau D., Foster M., Hogg M., Swiggett J., Holder W.D., White R.L, 2001. Angiogenic and immune  parameters  

     during  interferon-alpha2b adjuvant treatment in melanoma patients. Oncol Res, 12:241-251. Related Article

·        Brar S.S., Grigg C., Wilson K.S., Holder W.D. Jr, Dréau D., Austin C., Foster M., Ghio A.J., Whorton A.R.,

      Stowell G.W., Whittall L.B., Whittle R.R., White D.P., Kennedy T.P., 2004. Disulfiram inhibits activating

     transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent

     manner in vitro, in mice and in a patient with metastatic disease. Mol Cancer Ther. 3:1049-60.

·        Carbonell A.M., Matthews B.D., Dréau D., Foster M., Austin C.E., Kercher K.W., Sing R.F., Heniford B.T., 2005.